Keata Signs Consumer Supply Pact

Keata Pharma, a subsidiary of PharmEng International, has signed an agreement with an undisclosed global consumer healthcare company for the manufacture of branded non-prescription drug products for Canada and other international territories. This new agreement replaces an existing sub-contracting relationship between the two companies.
   
Under the agreement, Keata will supply the products for an initial two-year term beginning January 1, 2009 with an option to extend the agreement for two additional one-year terms.
   
“We are delighted to be continuing our relationship with this consumer healthcare company as the agreement underscores our dedication to quality and our commitment to continual cost improvement,” stated Alan Kwong, chief executive officer of PharmEng International. “This supply agreement comes as a part of other multi-year contracts and will help to properly optimize our production capacity.”